Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Chem Biol Interact. 2012 Oct 25;200(1):11-20. doi: 10.1016/j.cbi.2012.08.023. Epub 2012 Sep 13.
Licorice (LE) has been commonly used in traditional Chinese medicine (TCM) for over 4000 years to reconcile various drugs and for hepatic disorders. Glycyrrhizin is the main bioactive component isolated from LE herbs. In the present study we examined the effects of glycyrrhizin on pregnane X receptor (PXR)-mediated CYP3A expression and its hepatoprotective activity. Treatment of HepG2 cells with glycyrrhizin resulted in marked increase in both CYP3A4 mRNA and protein levels. The transcriptional activation of the CYP3A4 gene through glycyrrhizin is PXR-dependent, as shown in transient transfection experiments. Glycyrrhizin activates the DNA-binding capacity of the PXR for the CYP3A4 element responding to xenobiotic signals, as measured by the electrophoretic-mobility shift assay (EMSA). These results indicate that the induction of the hepatic CYP3A4 by glycyrrhizin is mediated through the activation of PXR. The next aim of the current study was to determine whether the activation of PXR and induction of CYP3A by glycyrrhizin prevents hepatotoxicity during cholestasis as a mechanism of hepatoprotection. Mice were pretreated with glycyrrhizin prior to induction of intrahepatic cholestasis using lithocholic acid (LCA). Pre-treatment with glycyrrhizin, as well as the PXR activator pregnenolone 16α-carbontrile (PCN), prevents the increase in plasma ALT and AST activity, multifocal necrosis and prevents an increase in a level of serum LCA level in mice, as compared with the results in the mice treated with LCA alone. Activation of the PXR by glycyrrhizin results in induction of CYP3A11 (CYP3A4 for human) expression and inhibition of CYP7A1 through an increase in small heterodimer partner (SHP) expression. Glycyrrhizin regulates the expression of the gene mentioned above to prevent toxic accumulation of bile acids in the liver and it also protects mouse livers from the harmful effects of LCA. In conclusion, PXR-mediated effects on CYP3A and CYP7A may contribute to the hepatoprotective property of glycyrrhizin against LCA-induced liver injury.
甘草(LE)在传统中药(TCM)中已被广泛使用了 4000 多年,用于调和各种药物和治疗肝脏疾病。甘草甜素是从 LE 草药中分离出的主要生物活性成分。在本研究中,我们研究了甘草甜素对孕烷 X 受体(PXR)介导的 CYP3A 表达及其肝保护活性的影响。甘草甜素处理 HepG2 细胞可显著增加 CYP3A4 mRNA 和蛋白水平。通过瞬时转染实验表明,CYP3A4 基因的转录激活依赖于 PXR。甘草甜素激活 PXR 对 CYP3A4 元件的 DNA 结合能力,该元件响应外源性信号,如电泳迁移率变动分析(EMSA)所示。这些结果表明,甘草甜素诱导的肝 CYP3A4 是通过激活 PXR 介导的。本研究的下一个目的是确定甘草甜素激活 PXR 和诱导 CYP3A 是否可预防胆汁淤积期间的肝毒性,作为肝保护的机制。在用石胆酸(LCA)诱导肝内胆汁淤积之前,用甘草甜素预处理小鼠。与单独用 LCA 处理的小鼠相比,用甘草甜素预处理以及 PXR 激活剂孕烯醇酮 16α-氰化物(PCN)预处理可防止血浆 ALT 和 AST 活性升高、多灶性坏死,并防止血清 LCA 水平升高。甘草甜素通过增加小异二聚体伴侣(SHP)的表达来激活 PXR,从而诱导 CYP3A11(人 CYP3A4)的表达并抑制 CYP7A1。甘草甜素调节上述基因的表达,以防止有毒的胆汁酸在肝脏中积累,并保护小鼠肝脏免受 LCA 的有害影响。总之,PXR 对 CYP3A 和 CYP7A 的影响可能有助于甘草甜素对 LCA 诱导的肝损伤的肝保护作用。